Safety and T1 Reactivity for Vasodilator Stress Ferumoxytol-Enhanced Cardiac Magnetic Resonance Imaging

By afschroeder • March 22, 2026

Pogosyan A, Keushkerian MJ, Ming Z, Mahmoudi M, Sim MS, Li Y, Finn JP, Nguyen KL. Safety and T₁Reactivity for Vasodilator Stress Ferumoxytol-Enhanced Cardiac Magnetic Resonance Imaging. J Cardiovasc Magn Reson. 2026 Mar 19:102719. doi: 10.1016/j.jocmr.2026.102719. Epub ahead of print. PMID: 41864344.

Tags: cardiac magnetic resonance, Cardiology/Epi, contrast media, coronary artery disease, DOM STAT, ferumoxytol, General Internal Medicine, ischemic heart disease, Magnetic resonance imaging, myocardial perfusion, Post Doc, Publications, stress CMR, T(1) reactivity, ultrasmall superparamagnetic iron oxide nanoparticles (USPIO), Veterans Administration

Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase in Aeromonas spp

von Bredow B, Trejo M, Ward KW, Trieu KP, Santellan CA, Garner OB, Yang S, Chandrasekaran S. Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase[...]

Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial

Budoff MJ, Verghese D, Kinninger A, Lakshmanan S. Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial. Eur Heart J Cardiovasc Imaging. 2026[...]

Timeliness of Transthyretin Cardiac Amyloidosis Diagnosis in the Medicare Population

Spencer-Bonilla G, Fan J, Cheng P, Din N, Rodriguez F, Davies M, Papas MA, Huang J, Venditto J, Witteles RM, Heidenreich P, Alexander K, Sandhu[...]